Whole population | “Few multimorbidity-related medications” profile | “Predominantly allergic multimorbidity-related medications” profile | “Predominantly metabolic multimorbidity-related medications” profile | p-value | |
Women | 4328 | 1885 | 1419 | 1024 | |
Sociodemographic characteristics | |||||
Age years | 69.6±6.1 | 68.9±5.9 | 69.3±5.8 | 71.6±6.5 | <0.0001 |
Educational level | |||||
Less than high school diploma | 449 (10.8) | 185 (10.1) | 118 (8.7) | 146 (14.9) | <0.0001 |
High school to level 2 university | 2050 (49.2) | 822 (45.1) | 700 (51.5) | 528 (53.8) | |
Level 3/4 university | 840 (20.2) | 416 (22.8) | 271 (19.9) | 153 (15.6) | |
Level ≥5 university | 826 (19.8) | 402 (22.0) | 270 (19.9) | 154 (15.7) | |
Asthma therapeutic management | |||||
High level of asthma maintenance therapy | 632 (14.6) | 95 (5.0) | 356 (25.1) | 181 (17.7) | <0.0001 |
Low level of asthma maintenance therapy | 620 (14.3) | 133 (7.1) | 327 (23.0) | 160 (15.6) | |
No asthma maintenance therapy | 3076 (71.1) | 1657 (87.9) | 736 (51.9) | 683 (66.7) | |
Asthma characteristics | |||||
Current asthma | 3023 (79.9) | 1119 (70.9) | 1098 (85.8) | 806 (87.3) | <0.0001 |
Late-onset asthma | 1455 (36.7) | 545 (31.5) | 517 (39.0) | 393 (43.3) | <0.0001 |
Asthma–COPD overlap | 863 (22.7) | 265 (15.9) | 353 (28.3) | 245 (27.5) | <0.0001 |
Adverse asthma events | |||||
Uncontrolled asthma | 522 (19.2) | 127 (12.2) | 214 (21.5) | 181 (26.7) | <0.0001 |
At least one asthma attack | 1055 (25.4) | 317 (17.5) | 438 (32.3) | 300 (30.6) | <0.0001 |
At least one asthma exacerbation | 446 (13.2) | 123 (8.8) | 206 (17.9) | 117 (14.3) | <0.0001 |
Total AQLQ score | 6.0±1.0 | 6.3±0.9 | 5.9±1.0 | 5.8±1.1 | <0.0001 |
Data are presented as n, mean±sd or n (%), unless otherwise stated. COPD: chronic obstructive pulmonary disease; AQLQ: Asthma Quality of Life Questionnaire.